Cargando…

Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure

Detalles Bibliográficos
Autores principales: Pieringer, Herwig, Schumacher, Sabine, Schmekal, Bernhard, Gitter, Thomas, Biesenbach, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421164/
https://www.ncbi.nlm.nih.gov/pubmed/25983879
http://dx.doi.org/10.1093/ndtplus/sfn030
_version_ 1782369806496825344
author Pieringer, Herwig
Schumacher, Sabine
Schmekal, Bernhard
Gitter, Thomas
Biesenbach, Georg
author_facet Pieringer, Herwig
Schumacher, Sabine
Schmekal, Bernhard
Gitter, Thomas
Biesenbach, Georg
author_sort Pieringer, Herwig
collection PubMed
description
format Online
Article
Text
id pubmed-4421164
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44211642015-05-15 Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure Pieringer, Herwig Schumacher, Sabine Schmekal, Bernhard Gitter, Thomas Biesenbach, Georg NDT Plus Letters Oxford University Press 2008-06 2008-04-09 /pmc/articles/PMC4421164/ /pubmed/25983879 http://dx.doi.org/10.1093/ndtplus/sfn030 Text en © The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letters
Pieringer, Herwig
Schumacher, Sabine
Schmekal, Bernhard
Gitter, Thomas
Biesenbach, Georg
Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
title Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
title_full Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
title_fullStr Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
title_full_unstemmed Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
title_short Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
title_sort gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421164/
https://www.ncbi.nlm.nih.gov/pubmed/25983879
http://dx.doi.org/10.1093/ndtplus/sfn030
work_keys_str_mv AT pieringerherwig gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure
AT schumachersabine gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure
AT schmekalbernhard gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure
AT gitterthomas gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure
AT biesenbachgeorg gadoliniumbasedcontrastagentserythropoietinandnephrogenicsystemicfibrosisinpatientswithendstagerenalfailure